autologous cord blood mononuclear cells

BIOLOGICAL3 trials

Sponsors

Guangdong Women and Children Hospital

Conditions

BPDImmunomodulation Effect

Phase 1

Effect of Autologous Cord Blood-mononuclear Cells Infusion on Immune Microenvironment in Infants Born Very Preterm in NICU

CompletedNCT05087498

Guangdong Women and Children HospitalImmunomodulation Effect

Start: 2021-11-28End: 2022-08-18Updated: 2024-01-02

Phase 3

Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia or Death in Extremely Preterm Neonates

Guangdong Women and Children HospitalBPD

Start: 2020-06-20End: 2023-12-31Target: 140Updated: 2023-11-01

Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates

Guangdong Women and Children HospitalBPD

Start: 2021-10-01End: 2023-09-30Target: 76Updated: 2021-10-08

Related Papers

Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes.

2023-02-1617 citations

Autologous cord blood mononuclear cell infusion for the prevention of bronchopulmonary dysplasia in very preterm monozygotic twins: A study protocol for a randomized, placebo-controlled, double-blinded multicenter trial

Frontiers in Pediatrics2022-12-09

Use of Autologous Cord Blood Mononuclear Cells Infusion for the Prevention of Bronchopulmonary Dysplasia in Extremely Preterm Neonates: A Study Protocol for a Placebo-Controlled Randomized Multicenter Trial [NCT04440670]

Frontiers in Pediatrics2020-04-021 citations